Insights

Digestive Disease Week 2026 convened clinicians, researchers, and industry partners with the aim of accelerating the translation of new evidence into clinical practice, featuring key insights into inflammatory bowel disease (IBD). The meeting was held in Chicago, Illinois from May 2-5th, 2026 and Helmsley’s Crohn’s Disease Team was on hand to connect with grantees and other leaders in IBD.

Each year on May 19th, we unite with the global community to raise awareness for people with inflammatory bowel diseases (IBD), which includes Crohn’s disease. As in years past, this World IBD Day, the Helmsley Building in New York City is lit purple as a symbol of solidarity with patients who have IBD.    

In philanthropy, innovation is sometimes thought of as investing in new technologies or breakthrough medical procedures. While less visible, however, investments in systems that coordinate people, protocols, and institutions already in place can yield significant and measurable improvements in outcomes.  “For philanthropic organizations, this work underscores an important lesson: meaningful improvements in health outcomes often depend less on new interventions and more…

Every seven seconds, a woman or a baby dies from preventable complications during pregnancy, childbirth or in the first few weeks of life. Neonatal deaths now account for nearly half of all deaths among children under five, with over half occurring in sub-Saharan Africa. Maternal and newborn survival is one of the clearest reflections of the quality of care that…

Helmsley Type 1 Diabetes Program Officer James Reid joined Jayasree Iyer on the Access to Medicine Foundation’s Health Equity Podcast to talk about closing the gap in type 1 diabetes care for people in low- and middle-income countries.   As James puts it, “What really matters is how we align our resources, our will, and our efforts to make sure…

Patricia “Patsy” Hudkins has watched the workplace video of her sudden cardiac arrest countless times, trying to find clues about what made that day different from any other shortly before her 39th birthday. One moment, she was reaching to get something for a customer at Finish Line Burgers & Brew in Velva, N.D. The next, she was dropping to the…

The 2026 Crohn’s and Colitis Congress convened clinicians, researchers, and industry partners with the aim to accelerate the translation of new evidence into clinical practice for inflammatory bowel disease (IBD) in Las Vegas, NV from January 22-24th, 2026. Crohn’s and Colitis Congress (CCCongress) offers opportunities for connection and collaboration — which we know are essential for success in driving research…

Hypoglycemia, or low blood sugar, is a dangerous complication of type 1 diabetes. It can lead to shakiness or confusion and in extreme cases, seizures, loss of consciousness, or even death. Frustratingly, too much insulin — the drug that people with type 1 diabetes (T1D) rely on daily to manage their blood sugar — can cause hypoglycemia. Diet and exercise…

We interviewed Scott B. Snapper, M.D., Ph.D., the Chief in the Division of Gastroenterology at Boston Children’s Hospital and a Professor of Medicine at Harvard Medical School, who is one of the principal leaders of the Very Early Onset Inflammatory Bowel Disease (VEO-IBD) Consortium. The Consortium — supported in part by Helmsley — unites leading pediatric gastroenterologists and scientists from…

It can be hard to manage type 1 diabetes — managing it through life changes and pregnancy is often even harder. Type 1 diabetes (T1D) affects millions of people and touches nearly every part of their lives. Yet there is a lack of good evidence and clinical guidelines for navigating how T1D intersects with pregnancy and women’s health. We know that…

As the global incidence of inflammatory bowel disease (IBD) continues to rise, innovative strategies for early identification, prevention, and treatment are urgently needed. The PROMISE (PRediction and PRevention through Omics, Microbiome, Immune System, and Environment) Consortium, is a collaborative initiative led by the Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital in Toronto, and Massachusetts General Hospital. Supported by Helmsley, PROMISE aims to advance…

The Rural Healthcare Program has granted more than $70 million toward ultrasound initiatives in four states, equipping hospitals and clinics with more than 600 devices, offering training opportunities to sonographers, and providing tuition assistance to those looking to enter the field.

At Helmsley, we are driven to help people living with type 1 diabetes (T1D) live healthier and more fulfilling lives. But we also know that T1D is part of a much broader challenge: the global crisis of noncommunicable diseases (NCDs).   On September 25th, world leaders gathered in New York for the 4th High-Level Meeting on Noncommunicable Diseases (NCDs) and…

Helmsley’s Type 1 Diabetes (T1D) Program hosted a one-day session on the occasion of the 60th Annual Meeting of the European Association for the Study of Diabetes. This scientific meeting explored the latest research into alpha and delta cell dysfunction leading to hypoglycemia, and efforts to therapeutically restore the body’s ability to reverse it.

Today, we’re highlighting the work of Alfred Kakisingi, in recognition of World Humanitarian Day. Here he shares how his organization — l’Association des Diabétiques du Congo (ADIC) — began, what daily life can look like for people with diabetes in Democratic Republic of the Congo, and how local leadership, persistence, and global solidarity are essential to delivering care where it’s…